CytomX Therapeutics Appoints Dr. Zhen Su to Board of DirectorsSOUTH SAN FRANCISCO, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced the...
Globe Newswire•4 months ago